Literature DB >> 17408234

Key elements of bioanalytical method validation for small molecules.

Surendra Bansal1, Anthony DeStefano.   

Abstract

Method validation is a process that demonstrates that a method will successfully meet or exceed the minimum standards recommended in the Food and Drug Administration (FDA) guidance for accuracy, precision, selectivity, sensitivity, reproducibility, and stability. This article discusses the validation of bioanalytical methods for small molecules with emphasis on chromatographic techniques. We present current thinking on validation requirements as described in the current FDA Guidance and subsequent 2006 Bioanalytical Methods Validation Workshop white paper.

Mesh:

Substances:

Year:  2007        PMID: 17408234      PMCID: PMC2751299          DOI: 10.1208/aapsj0901011

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  1 in total

1.  Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

Authors:  C T Viswanathan; Surendra Bansal; Brian Booth; Anthony J DeStefano; Mark J Rose; Jeffrey Sailstad; Vinod P Shah; Jerome P Skelly; Patrick G Swann; Russell Weiner
Journal:  Pharm Res       Date:  2007-04-26       Impact factor: 4.200

  1 in total
  48 in total

1.  Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Authors:  Angela Y Wehr; Wei-Ting Hwang; Ian A Blair; Kenneth H Yu
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

2.  Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots.

Authors:  Ricarda Jantos; Annemiek Vermeeren; Danica Sabljic; Johannes G Ramaekers; Gisela Skopp
Journal:  Int J Legal Med       Date:  2012-04-25       Impact factor: 2.686

Review 3.  Biomarker method validation in anticancer drug development.

Authors:  J Cummings; T H Ward; A Greystoke; M Ranson; C Dive
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 4.  Stable-isotope dilution LC–MS for quantitative biomarker analysis.

Authors:  Eugene Ciccimaro; Ian A Blair
Journal:  Bioanalysis       Date:  2010-02       Impact factor: 2.681

5.  Development and validation of an LC-MS/MS method for determination of the L-type voltage-gated calcium channel/NMDA receptor antagonist NGP1-01 in mouse serum.

Authors:  Harini Jogiraju; Xiang Zhou; Ashta Lakshmi Prasad Gobburi; Kiran K Pedada; Werner J Geldenhuys; Cornelis J Van der Schyf; Samuel D Crish; David J Anderson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-02       Impact factor: 3.205

6.  Determination of hexamethylene bisacetamide, an antineoplastic compound, in mouse and human plasma by LC-MS/MS.

Authors:  Kerri M Smith; Wannarasmi Ketchart; Xiang Zhou; Monica M Montano; Yan Xu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-06-13       Impact factor: 3.205

7.  Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.

Authors:  Felipe K Hurtado; Benjamin Weber; Hartmut Derendorf; Guenther Hochhaus; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

8.  Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.

Authors:  Richard Wiegand; Jianmei Wu; Xianyi Sha; Patricia LoRusso; Jing Li
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-11-27       Impact factor: 3.205

Review 9.  Validation of analytic methods for biomarkers used in drug development.

Authors:  Cindy H Chau; Olivier Rixe; Howard McLeod; William D Figg
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

10.  Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist.

Authors:  Timothy Wyant; Alan Lackey; Marie Green
Journal:  J Transl Med       Date:  2008-12-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.